HSF1: Transcriptional Master of the Heat Shock Response
Heat shock factor 1 (HSF1) is the primary transcription factor driving heat shock protein gene expression. Under basal conditions, HSF1 is maintained in an inactive monomer state by interaction with HSP90 and HSP70/HSPA1A (which bind the HSF1 regulatory domain, sensing free chaperone availability). Proteotoxic stress, including heat, heavy metals, oxidative stress, and misfolded protein accumulation, titrates HSP90 and HSP70 away from HSF1, allowing HSF1 to trimerize, hyperphosphorylate (Ser326 activating, Ser307/303 inhibitory), and bind heat shock elements (HSEs: nGAAn repeats in triplicate) in target gene promoters.
HSP70 (HSPA1A): ATP-Driven Holdase and Foldase
Cytosolic HSP70 (HSPA1A) and its constitutive cognate HSC70 (HSPA8) use ATP hydrolysis (stimulated by J-domain co-chaperones: DNAJB1/HSP40) to cycle between substrate-binding (ADP-bound, high affinity) and release (ATP-bound, low affinity) states. HSP70 prevents aggregation of newly synthesised or stress-denatured proteins and cooperates with HSP40 and GrpE/BAG family nucleotide exchange factors. HSP70 also targets misfolded proteins for CHIP (C-terminus of HSP70-interacting protein) ubiquitination and proteasomal degradation, or for chaperone-mediated autophagy (CMA) via LAMP2A. Spirulina generates mild oxidative/proteotoxic stress (PCB as a Michael acceptor) that transiently activates HSF1 without sustained proteotoxicity, inducing HSP70 through a hormetic mechanism.
HSP90: Client Protein Maturation and Stability
HSP90 (HSP90AA1/alpha, HSP90AB1/beta) is an abundant dimeric ATPase that matures a select set of client proteins requiring its chaperone cycle, including kinases (Akt, EGFR, CDK4, RAF), steroid hormone receptors (GR, AR, ER), and transcription factors (HIF-1alpha, p53). The HSP90 chaperone cycle involves co-chaperones CDC37 (kinase loading), HOP/STIP1 (HSP70-HSP90 bridge), p23/PTGES3 (ATPase inhibitor stabilising mature complex), and FKBP51/52 (immunophilins). HSP90 inhibition (geldanamycin/17-AAG) depletes client proteins including HIF-1alpha and Akt. Spirulina's HSP90 induction (via HSF1) may paradoxically stabilise both oncogenic and tumour-suppressive clients, making client-specific context important.
Small HSPs: Alpha-Crystallin and HSPB Family
Small heat shock proteins (sHSPs, HSPB1-10) are ATP-independent holdases that capture aggregation-prone proteins and deliver them to HSP70 for refolding. HSPB1 (HSP27) is phosphorylated by MAPKAPK2 (downstream of p38-MAPK) at Ser15/27/82, releasing oligomers and increasing F-actin stabilisation and anti-apoptotic activity. HSPB5 (alphaB-crystallin/CRYAB) is abundant in lens, heart, and brain, and sequesters alpha-synuclein aggregates. Spirulina's p38-MAPK attenuation (via DUSP1 induction) reduces HSPB1 phosphorylation, favouring oligomeric holdase function over actin-stabilising function.
Proteostasis Network Integration
The proteostasis network integrates three disposal systems: (1) the proteasome (26S/20S for ubiquitinated substrates), (2) autophagy/lysosome (misfolded aggregates, organelles), and (3) the chaperome (HSP70/90/small HSPs for refolding). AMPK activates both autophagy (via ULK1 Ser317/777) and the proteasome (via PSMB5 induction). Nrf2 activates proteasome subunit genes (PSMA/PSMB genes have AREs) and the deubiquitinase UCHL1. Spirulina thus supports all three proteostasis arms simultaneously, explaining cytoprotective effects in protein aggregation disease models (MPTP-Parkinson, Abeta-Alzheimer) described in the literature.
HSP70 Extracellular Functions: Danger Signalling
Beyond intracellular chaperone function, extracellular HSP70 (eHSP70) released from stressed or necrotic cells acts as a danger-associated molecular pattern (DAMP), activating TLR2/TLR4 on antigen-presenting cells to stimulate innate and adaptive immunity. eHSP70 also facilitates cross-presentation of chaperoned peptides on MHC class I, supporting anti-tumour immunity. The context of spirulina-induced mild HSP70 release (hormetic stress) versus tissue-damage-driven release is an important distinction for interpreting immunomodulatory effects.
Related Reading
Get the weekly digest
Curated science, recipes, and brand intel — once a week, no spam, unsubscribe in one click.
